Navigation Links
PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
Date:12/21/2011

BOSTON, Dec. 21, 2011 /PRNewswire/ -- To help emerging and mid-size biopharmaceutical companies address an increasingly challenging regulatory and commercial environment, PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it is introducing a series of executive briefings with clinical operations and outsourcing leaders worldwide.  During these forums, PAREXEL will discuss how a spectrum of proven operating practices and relationship models can significantly reduce timelines and costs and streamline protocols and programs.

Through these educational briefings, designed for emerging and mid-size biopharmaceutical companies, PAREXEL senior project leaders and teams will discuss customized solutions that can assist companies in achieving their short- and long-term development and commercialization milestones. The teams will address key issues that may impact critical areas for emerging and mid-sized biopharmaceutical companies, including:

  • Optimizing patient recruitment strategy
  • Meeting "first patient in" timelines
  • Accessing real-time data
  • Achieving database lock timelines
  • Accelerating the speed of site recruitment
  • Implementing risk management and contingency planning approaches
  • "Deep collaboration with emerging and mid-size biopharmaceutical companies has been part of our DNA for nearly 30 years. We are committed to continuing to work with these clients to help them navigate the next stages of their businesses in the 'niche-buster' era, and in a challenging regulatory and commercial environment," said Mark A. Goldberg, M.D., Chief Operating Officer, PAREXEL. "Through a flexible and innovative approach, we create solutions that are the 'right fit' for every client. We're looking forward to bringing th
    '/>"/>

    SOURCE PAREXEL International Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. PAREXEL Closes the Acquisition of ClinPhone
    2. PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
    3. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
    4. PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors
    5. PAREXEL International to Present at William Blair Small-Cap Growth Stock Conference
    6. PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average
    7. PAREXEL Corporate Vice President Dr. Alberto Grignolo Receives Lifetime Achievement Award From Good Clinical Practice Journal
    8. PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy
    9. PAREXEL International to Present at Oppenheimer 19th Annual Healthcare Conference
    10. PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress
    11. PAREXEL Expands Pioneering Asian Ethnobridging Expertise
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/16/2015)... , April 16, 2015 /PRNewswire/ - Portage Biotech ... Canadian Securities Exchange: PBT.U), is pleased to announce that ... Show on April 25, 2015 to be held in ... Gregory Bailey and Mr. James Mellon ... and an update on the key programs at its ...
    (Date:4/16/2015)... MOSCOW , April 16, 2015 /PRNewswire/ ... (ChemRar), the Russian pharmaceutical investment and R&D ... announced collaboration for research, development and commercialization ... with the intention to stimulate ... industry.      (Logo: http://photos.prnewswire.com/prnh/20150416/739742-a) ,     ...
    (Date:4/16/2015)... April 16, 2015  Scientists from Cleave Biosciences will ... the Horizon," at the American Association for Cancer Research ... on Sunday, April 19, 2015 from 3:15pm to ... of Biology, will present new in vivo and mechanism ... inhibitor of p97, a critical enzyme that controls various ...
    (Date:4/16/2015)... , April 16, 2015 ... ™ , a Swiss-based global biopharmaceutical company ... needs as well as companion diagnostics, today ... compounds Debio 1143 (SMAC mimetic) and Debio 1347/CH5183284 (FGFR ... 2015 Annual meeting of the American Association for Cancer Research (AACR) ...
    Breaking Biology Technology:Portage to Present at Master Investor 2015 in London, UK 2Portage to Present at Master Investor 2015 in London, UK 3Portage to Present at Master Investor 2015 in London, UK 4Lancet and ChemRar High Tech Center Have Announced a Partnership in the Development and Production of Novel Drugs in Russia 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 3Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3
    ... 2011 Reportlinker.com announces that a new ... catalogue: Global Biosimilars Industry ... This report analyzes the worldwide markets ... provides separate comprehensive analytics for US, Europe, ...
    ... 2011 Reportlinker.com announces that a ... in its catalogue: ... http://www.reportlinker.com/p0459150/Global-Micro-Electromechanical-Systems-MEMs-Devices-Industry.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Electronic_Component_and_Semiconductor ... worldwide markets for Micro-Electromechanical Systems (MEMS) ...
    ... 19, 2011 Reportlinker.com announces that a ... its catalogue: Enzymes: Sustainable ... http://www.reportlinker.com/p0501016/Enzymes-Sustainable-Alternatives-with-Remarkable-Scope.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical Enzymes are ... playing a whole host of different roles ...
    Cached Biology Technology:Global Biosimilars Industry 2Global Biosimilars Industry 3Global Biosimilars Industry 4Global Biosimilars Industry 5Global Biosimilars Industry 6Global Biosimilars Industry 7Global Biosimilars Industry 8Global Biosimilars Industry 9Global Biosimilars Industry 10Global Micro-Electromechanical Systems (MEMs) Devices Industry 2Global Micro-Electromechanical Systems (MEMs) Devices Industry 3Global Micro-Electromechanical Systems (MEMs) Devices Industry 4Global Micro-Electromechanical Systems (MEMs) Devices Industry 5Global Micro-Electromechanical Systems (MEMs) Devices Industry 6Global Micro-Electromechanical Systems (MEMs) Devices Industry 7Global Micro-Electromechanical Systems (MEMs) Devices Industry 8Global Micro-Electromechanical Systems (MEMs) Devices Industry 9Global Micro-Electromechanical Systems (MEMs) Devices Industry 10Global Micro-Electromechanical Systems (MEMs) Devices Industry 11Global Micro-Electromechanical Systems (MEMs) Devices Industry 12Global Micro-Electromechanical Systems (MEMs) Devices Industry 13Global Micro-Electromechanical Systems (MEMs) Devices Industry 14Global Micro-Electromechanical Systems (MEMs) Devices Industry 15Global Micro-Electromechanical Systems (MEMs) Devices Industry 16Global Micro-Electromechanical Systems (MEMs) Devices Industry 17Global Micro-Electromechanical Systems (MEMs) Devices Industry 18Global Micro-Electromechanical Systems (MEMs) Devices Industry 19Global Micro-Electromechanical Systems (MEMs) Devices Industry 20Global Micro-Electromechanical Systems (MEMs) Devices Industry 21Global Micro-Electromechanical Systems (MEMs) Devices Industry 22Global Micro-Electromechanical Systems (MEMs) Devices Industry 23Global Micro-Electromechanical Systems (MEMs) Devices Industry 24Reportlinker Adds Enzymes: Sustainable Alternatives with Remarkable Scope 2Reportlinker Adds Enzymes: Sustainable Alternatives with Remarkable Scope 3
    (Date:4/2/2015)... 2015 According to preliminary estimates ... somewhat higher than 125 MSEK. This exceeds the guidance ... that revenues for Q1 2015 would be in line ... Q4 2014. The operating result for the first quarter ... interim report will as previously communicated be published on ...
    (Date:3/31/2015)... 31, 2015  Elephant Talk Communications Corp. (NYSE MKT: ... of Software Defined Network Architecture (ET Software DNA® 2.0) ... of approximately $20.4 million for the year ended December ... for the year ended December 31, 2013. ... had completed its multi-year transition away from its legacy ...
    (Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
    Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
    ... the worlds poorest regions could face severe crop losses in ... a new study by researchers at Stanford Universitys Program on ... be published in the Feb. 1 issue of the journal ... depend on agriculture for their livelihoods, said lead author David ...
    ... TEMPE, Ariz. -- Water has some amazing properties. It is ... solid, liquid and gas within the range of natural ... liquid form, which is why ice floats. It can absorb ... high surface tension (helping it move through roots and capillaries ...
    ... approval process for medical devices does not involve the ... to change in order to improve health outcomes, say ... The UCSF team analyzes the problem and ... in the January 2008 issue of the Journal of ...
    Cached Biology News:Impoverished areas of Africa and Asia face severe crop losses from climate change in 20 years 2Impoverished areas of Africa and Asia face severe crop losses from climate change in 20 years 3Impoverished areas of Africa and Asia face severe crop losses from climate change in 20 years 4ASU professor helps solve mystery of glassy water 2ASU professor helps solve mystery of glassy water 3Analysis calls for medical device information to better serve patients and doctors 2Analysis calls for medical device information to better serve patients and doctors 3
    Sulfadimethoxine (CH-2027)...
    Bovine Pulmonary Artery Smooth Muscle Cells (BPASMC) (>500,000 cells)...
    ... is designed for imaging of chemiluminescent, fluorescent ... offer direct control for users who wish ... hand , A range of high resolution, ... all fluorescent and chemiluminescent applications , ...
    PC based system for advanced chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
    Biology Products: